Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Sara Bremer"'
Publikováno v:
Research in socialadministrative pharmacy : RSAP. 18(11)
Drug-related problems (DRPs) lead to substantial morbidity and mortality and increase healthcare costs. Several interventions have been developed to reduce DRPs and improve the outcome of drug therapy.To investigate DRPs identified through a pharmaci
Autor:
Christine Berg Nordahl, Anders Mikal Andersen, Nils Tore Vethe, Kristine Hole, Rolf Anton Klaasen, Stein Bergan, Morten Skauby, Karsten Midtvedt, Sara Bremer
Publikováno v:
British Journal of Clinical Pharmacology
Aims To explore the pharmacodynamics of mycophenolic acid (MPA) through inosine monophosphate dehydrogenase (IMPDH) capacity measurement and purine levels in peripheral blood mononuclear cells (PBMC) longitudinally during the first year after renal t
Autor:
Christine Frigaard, Solveig Henjum, Erik Magnus Sæther, Ragnar Hovland, Sara Bremer, Per Kristian Faksvåg, Ivar Sønbø Kristiansen
Publikováno v:
The International Journal of Pharmacy Practice
Objective To examine whether a pharmacist-led intervention improves medication adherence among patients who have filled a first-time prescription for a cardiovascular medicine. Methods Design: Unblinded randomized controlled trial. Setting: 67 Norweg
Autor:
Anja Svarstad, Anna Bjerre, Nils Tore Vethe, Ragnhild Heier Skauby, Sara Bremer, Stein Bergan, Ingjerd Sæves
Publikováno v:
Therapeutic Drug Monitoring. 39:472-482
Prednisolone is a standard component of immunosuppressive protocols in renal transplantation (Tx) and despite standardized treatment regimens, adverse side effects are still frequent. The aim of this study was to characterize the pharmacokinetics of
Autor:
Sara Bremer, Margrete Kasbo, Morten Skauby, Nils Tore Vethe, Elisabet D. Johansson, Stein Bergan, Karsten Midtvedt
Publikováno v:
British Journal of Clinical Pharmacology. 83:2494-2502
SUMMARYAIMS Despite pharmacokinetic monitoring of calcineurin inhibitors, the long-term outcome after transplantation (Tx) is still hampered by the side effects of these drugs. The aim of this study was to characterize the nuclear factor of activated
Publikováno v:
Clinical Biochemistry. 49:411-418
The individual and interindividual variability of response to immunosuppressants combined with the prevailing concept of lifelong immunosuppression following any organ transplantation motivates the search for methods to further individualize such the
Autor:
Anders Mikal Andersen, Lina Daleq, Stein Bergan, Morten Skauby, Karsten Midtvedt, Nils Tore Vethe, Rolf Anton Klaasen, Sara Bremer
Publikováno v:
Therapeutic drug monitoring. 40(5)
Tacrolimus (TAC) is an immunosuppressive drug used after organ transplantation. Dosing is adjusted using whole blood (WB-TAC) measurements. Patients within the therapeutic WB-TAC window still experience rejections and adverse effects. Alternative mon
Autor:
Morten Skauby, Elisabet Størset, Stein Bergan, Karsten Midtvedt, Sara Bremer, Michael Neely, Anders Åsberg
Publikováno v:
Transplantation. 99:2158-2166
Early after renal transplantation, it is often challenging to achieve and maintain tacrolimus concentrations within the target range. Computerized dose individualization using population pharmacokinetic models may be helpful. The objective of this st
Publikováno v:
Therapeutic Drug Monitoring
Supplemental Digital Content is Available in the Text.
Background: Busulfan (Bu) and cyclophosphamide (Cy) are frequently included in conditioning regimens before hematopoietic stem cell transplantation (HSCT). Both drugs are detoxified by gluta
Background: Busulfan (Bu) and cyclophosphamide (Cy) are frequently included in conditioning regimens before hematopoietic stem cell transplantation (HSCT). Both drugs are detoxified by gluta
Autor:
Nils Tore Vethe, Sara Bremer, Stein Bergan, Anders Åsberg, Ida Robertsen, Aleksander Olsen Ingerø, Karsten Midtvedt
Publikováno v:
Transplantation. 99:528-532
Proper bioequivalence studies comparing original with generic immunosuppressive drugs in patients are limited, especially in the increasing population of elderly renal transplant recipients. We performed an open-label, single-center, prospective, ran